|
|
||||||||
Clinical Trials Division, Family Health International, Research Triangle Park, NC 27709.
OBJECTIVES. The purpose of the study was to determine the contraceptive efficacy of the female condom and to provide data about the device to the US Food and Drug Administration. METHODS. The clinical trial was conducted at six US sites and three sites in Latin America. Eligible subjects were in mutually monogamous relationships and agreed to use the female condom as their only means of contraception for 6 months. RESULTS. A total of 328 subjects contributed to the analysis of contraceptive efficacy. Twenty-two US subjects and 17 Latin American subjects became pregnant, yielding 6-month gross cumulative accidental pregnancy rates of 12.4 and 22.2, respectively. During perfect (consistent and correct) use of the method, the 6-month accidental pregnancy rates were 2.6 and 9.5 for the US and Latin American centers, respectively. There were no serious adverse events related to the use of the method. CONCLUSIONS. The female condom provides contraceptive efficacy in the same range as other barrier methods, particularly when used consistently and correctly, and has the added advantage of helping protect against sexually transmitted diseases.
This article has been cited by other articles:
![]() |
L. Bahamondes, J. Diaz, N. M. Marchi, S. Castro, M. Villarroel, and M. Macaluso Prostate-specific antigen in vaginal fluid after exposure to known amounts of semen and after condom use: comparison of self-collected and nurse-collected samples Hum. Reprod., July 29, 2008; (2008) den283v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Artz, M. Macaluso, J. Kelaghan, H. Austin, M. Fleenor, L. Robey, E. W. Hook III, and I. Brill An Intervention to Promote the Female Condom to Sexually Transmitted Disease Clinic Patients Behav Modif, March 1, 2005; 29(2): 318 - 369. [Abstract] [PDF] |
||||
![]() |
H S Mitchell and E Stephens Contraception choice for HIV positive women Sex. Transm. Inf., June 1, 2004; 80(3): 167 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Raney and J. Methot Recent Advances in Hormonal and Barrier Contraception Journal of Pharmacy Practice, June 1, 2003; 16(3): 209 - 217. [Abstract] [PDF] |
||||
![]() |
M. L. Lawson, M. Macaluso, A. Duerr, G. Hortin, K. R. Hammond, R. Blackwell, L. Artz, and A. Bloom Partner Characteristics, Intensity of the Intercourse, and Semen Exposure During Use of the Female Condom Am. J. Epidemiol., February 15, 2003; 157(4): 282 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Macaluso, M. L. Lawson, G. Hortin, A. Duerr, K. R. Hammond, R. Blackwell, and A. Bloom Efficacy of the Female Condom as a Barrier to Semen During Intercourse Am. J. Epidemiol., February 15, 2003; 157(4): 289 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Greydanus, D. R. Patel, and M. E. Rimsza Contraception in the Adolescent: An Update Pediatrics, March 1, 2001; 107(3): 562 - 573. [Abstract] [Full Text] |
||||
![]() |
H. L. SURRATT, W. M. WECHSBERG, L. B. COTTLER, C. G. LEUKEFELD, H. KLEIN, and D. P. DESMOND Acceptability of the Female Condom Among Women at Risk for HIV Infection American Behavioral Scientist, May 1, 1998; 41(8): 1157 - 1170. [Abstract] |
||||
![]() |
L. J. Moore "It's Like You Use Pots and Pans to Cook. It's the Tool": The Technologies of Safer Sex Science Technology Human Values, October 1, 1997; 22(4): 434 - 471. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |